About | The Journal for ImmunoTherapy of Cancer. Best Practices for Mentoring journal for immunotherapy of cancer impact factor 2023 and related matters.. Acceptance rate: 21% ; Impact Factor (JCR): 10.3 ; IF rank (Oncology): 26/322 ; IF rank (Immunology): 12/181 ; Citescore: 17.7.
Journal of Immunotherapy
Immunotherapy | Taylor & Francis Online
Journal of Immunotherapy. Editor-in-Chief: Steven A. Rosenberg, MD, PhD · ISSN: 1524-9557 · Online ISSN: 1537-4513 · Frequency: 9 issues per year · Ranking: Oncology 129/322. The Rise of Digital Marketing Excellence journal for immunotherapy of cancer impact factor 2023 and related matters.. Immunology 99/ , Immunotherapy | Taylor & Francis Online, Immunotherapy | Taylor & Francis Online
About JITC - Society for Immunotherapy of Cancer (SITC)
Cancers | Announcements
About JITC - Society for Immunotherapy of Cancer (SITC). The Journal for ImmunoTherapy of Cancer (JITC) is the official open access Background Obesity is a risk factor for developing cancer but is also , Cancers | Announcements, Cancers | Announcements. The Impact of Competitive Intelligence journal for immunotherapy of cancer impact factor 2023 and related matters.
Home | Cancer Immunology, Immunotherapy
*The history and advances in cancer immunotherapy: understanding *
Home | Cancer Immunology, Immunotherapy. Journal Impact Factor: 4.6 (2023). 5-year Journal Impact Factor: 5.4 (2023). Top Picks for Insights journal for immunotherapy of cancer impact factor 2023 and related matters.. Submission to first decision (median): 4 days. Downloads: 1,142,964 (2023). Calls , The history and advances in cancer immunotherapy: understanding , The history and advances in cancer immunotherapy: understanding
About | The Journal for ImmunoTherapy of Cancer
About JITC - Society for Immunotherapy of Cancer (SITC)
Top Tools for Understanding journal for immunotherapy of cancer impact factor 2023 and related matters.. About | The Journal for ImmunoTherapy of Cancer. Acceptance rate: 21% ; Impact Factor (JCR): 10.3 ; IF rank (Oncology): 26/322 ; IF rank (Immunology): 12/181 ; Citescore: 17.7., About JITC - Society for Immunotherapy of Cancer (SITC), About JITC - Society for Immunotherapy of Cancer (SITC)
Journal for ImmunoTherapy of Cancer
*Mucosal-associated invariant T cells for cancer immunotherapy *
Journal for ImmunoTherapy of Cancer. 2023, Q1. The Role of Customer Service journal for immunotherapy of cancer impact factor 2023 and related matters.. Molecular Medicine, 2014, Q3. Molecular Medicine, 2015, Q1 The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric., Mucosal-associated invariant T cells for cancer immunotherapy , Mucosal-associated invariant T cells for cancer immunotherapy
Journal for ImmunoTherapy of Cancer | ICI Journals Master List
*Cancers | Highly Viewed Papers and Hot Topic Special Issues on *
Journal for ImmunoTherapy of Cancer | ICI Journals Master List. BioMed Central Ltd. -, 2020, 2021, 2022, 2023, 2024. Journal Impact Factor [IF] Non-indexed in the ICI Journals Master List 2023. Best Options for Expansion journal for immunotherapy of cancer impact factor 2023 and related matters.. Not reported for evaluation., Cancers | Highly Viewed Papers and Hot Topic Special Issues on , Cancers | Highly Viewed Papers and Hot Topic Special Issues on
Journal for ImmunoTherapy of Cancer - Impact Factor & Score 2025
Homepage | The Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer - Impact Factor & Score 2025. The Evolution of Business Knowledge journal for immunotherapy of cancer impact factor 2023 and related matters.. The journal focuses largely on the fields of Immunotherapy, Cancer research, Immune system, Internal medicine and Tumor microenvironment., Homepage | The Journal for ImmunoTherapy of Cancer, Homepage | The Journal for ImmunoTherapy of Cancer
The Journal for ImmunoTherapy of Cancer: Homepage
Journal for ImmunoTherapy of Cancer on LinkedIn: #jitc
The Journal for ImmunoTherapy of Cancer: Homepage. The Impact of Digital Strategy journal for immunotherapy of cancer impact factor 2023 and related matters.. Impact Factor: 10.3. Citescore: 17.7. All metrics ». The Journal for Restricting. Clinical/translational cancer immunotherapy: Impact of select , Journal for ImmunoTherapy of Cancer on LinkedIn: #jitc, Journal for ImmunoTherapy of Cancer on LinkedIn: #jitc, The history and advances in cancer immunotherapy: understanding , The history and advances in cancer immunotherapy: understanding , Journal of ImmunoTherapy of Cancer Editorial Board members have agreed and †Founding Editor-in-Chief (2013-2023). Publishing Team. Head of Portfolio
